The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

Abstract As healthcare costs continue to rise, there has been great interest in understanding and defining the value of current therapeutic strategies for the treatment of cancer. Cancer immunotherapy has emerged as a clinically beneficial alternative to conventional therapies for a variety of malig...

Full description

Bibliographic Details
Main Authors: Howard L. Kaufman, Michael B. Atkins, Adam P. Dicker, Heather S. Jim, Louis P. Garrison, Roy S. Herbst, William T. McGivney, Steven Silverstein, Jon M. Wigginton, Peter P. Yu
Format: Article
Language:English
Published: BMJ Publishing Group 2017-04-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Cancer immunotherapy
Value
Cost
Summit
Biomarkers
Patient-reported outcomes
Online Access:http://link.springer.com/article/10.1186/s40425-017-0241-6

Internet

http://link.springer.com/article/10.1186/s40425-017-0241-6

Similar Items